Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.

<h4>Introduction</h4>Human papillomavirus (HPV) is the most common sexually transmitted infection, attributed to 4.5% of all cancers worldwide. Co-infection with the metabolic syndrome (MetS), a common cluster of cardiometabolic risk factors, has been shown to increase the persistence of...

Full description

Bibliographic Details
Main Authors: Parmis Mirzadeh, Akinkunle Oye-Somefun, Chris I Ardern, Catriona J Buick
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299479&type=printable
_version_ 1797263508155400192
author Parmis Mirzadeh
Akinkunle Oye-Somefun
Chris I Ardern
Catriona J Buick
author_facet Parmis Mirzadeh
Akinkunle Oye-Somefun
Chris I Ardern
Catriona J Buick
author_sort Parmis Mirzadeh
collection DOAJ
description <h4>Introduction</h4>Human papillomavirus (HPV) is the most common sexually transmitted infection, attributed to 4.5% of all cancers worldwide. Co-infection with the metabolic syndrome (MetS), a common cluster of cardiometabolic risk factors, has been shown to increase the persistence of HPV. The purpose of this study was to estimate the association between HPV and MetS on mortality risk.<h4>Methods</h4>Data for the current study was drawn from seven consecutive cycles (2003-2004 to 2015-2016) of the U.S. NHANES. The final analytic sample consisted of 5,101 individuals aged 18-65y with HPV and MetS information with follow-up to Dec. 31st, 2019. Baseline HPV status was assessed by either vaginal swab, penile swab or oral rinse and used to classify participants as: no HPV (n = 1,619), low (n = 1,138), probable (n = 672), and high-risk (n = 1,672; 22% type 16, and 10% type 18) HPV using IARC criteria. MetS was assessed by the Harmonized criteria.<h4>Results</h4>The average follow-up was 9.4 y with 240 all-cause deaths (no HPV: n = 46 deaths; low-risk: n = 60 deaths; probable: n = 37 deaths, and; high-risk: n = 97 deaths). HPV status alone revealed no associations with mortality in fully adjusted models. Cross-classification into discrete MetS/HPV strata yielded an increased risk of mortality in females with high-risk HPV/MetS relative to the no MetS/no HPV group.<h4>Conclusions</h4>In this study, low, probable, and high-risk HPV and MetS were differentially related to mortality risk in men and women. Further work is necessary to separate the temporal, age, vaccination, and sex effects of HPV diagnosis in these relationships using prospective studies with detailed histories of HPV infection and persistence.
first_indexed 2024-04-25T00:14:07Z
format Article
id doaj.art-09d3afd3c3c24d918df96ac4a01317f5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-25T00:14:07Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-09d3afd3c3c24d918df96ac4a01317f52024-03-13T05:31:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01193e029947910.1371/journal.pone.0299479Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.Parmis MirzadehAkinkunle Oye-SomefunChris I ArdernCatriona J Buick<h4>Introduction</h4>Human papillomavirus (HPV) is the most common sexually transmitted infection, attributed to 4.5% of all cancers worldwide. Co-infection with the metabolic syndrome (MetS), a common cluster of cardiometabolic risk factors, has been shown to increase the persistence of HPV. The purpose of this study was to estimate the association between HPV and MetS on mortality risk.<h4>Methods</h4>Data for the current study was drawn from seven consecutive cycles (2003-2004 to 2015-2016) of the U.S. NHANES. The final analytic sample consisted of 5,101 individuals aged 18-65y with HPV and MetS information with follow-up to Dec. 31st, 2019. Baseline HPV status was assessed by either vaginal swab, penile swab or oral rinse and used to classify participants as: no HPV (n = 1,619), low (n = 1,138), probable (n = 672), and high-risk (n = 1,672; 22% type 16, and 10% type 18) HPV using IARC criteria. MetS was assessed by the Harmonized criteria.<h4>Results</h4>The average follow-up was 9.4 y with 240 all-cause deaths (no HPV: n = 46 deaths; low-risk: n = 60 deaths; probable: n = 37 deaths, and; high-risk: n = 97 deaths). HPV status alone revealed no associations with mortality in fully adjusted models. Cross-classification into discrete MetS/HPV strata yielded an increased risk of mortality in females with high-risk HPV/MetS relative to the no MetS/no HPV group.<h4>Conclusions</h4>In this study, low, probable, and high-risk HPV and MetS were differentially related to mortality risk in men and women. Further work is necessary to separate the temporal, age, vaccination, and sex effects of HPV diagnosis in these relationships using prospective studies with detailed histories of HPV infection and persistence.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299479&type=printable
spellingShingle Parmis Mirzadeh
Akinkunle Oye-Somefun
Chris I Ardern
Catriona J Buick
Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
PLoS ONE
title Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
title_full Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
title_fullStr Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
title_full_unstemmed Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
title_short Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
title_sort association between human papillomaviruses metabolic syndrome and all cause death analysis of the u s nhanes 2003 2004 to 2015 2016
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299479&type=printable
work_keys_str_mv AT parmismirzadeh associationbetweenhumanpapillomavirusesmetabolicsyndromeandallcausedeathanalysisoftheusnhanes20032004to20152016
AT akinkunleoyesomefun associationbetweenhumanpapillomavirusesmetabolicsyndromeandallcausedeathanalysisoftheusnhanes20032004to20152016
AT chrisiardern associationbetweenhumanpapillomavirusesmetabolicsyndromeandallcausedeathanalysisoftheusnhanes20032004to20152016
AT catrionajbuick associationbetweenhumanpapillomavirusesmetabolicsyndromeandallcausedeathanalysisoftheusnhanes20032004to20152016